Benzinga's Top Initiations
October 26, 2016 at 11:02 AM EDT
Analysts at Aegis Capital initiated coverage on Heron Therapeutics Inc (NASDAQ: HRTX) with a Buy rating. The price ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.